Edgewise Therapeutics, Inc. (EWTX)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

11

0

1

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Oct-24 4:23 PM View:	11-Oct-24 Option Exercise $49.70K	Carruthers R Michael Chief Financial Officer		Edgewise Therapeutics, Inc. - EWTX	114% 35.93K to 76.9K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 8:24 PM View:	20-Sep-24 Option Sale ($1.22M)	Derakhshan Behrad Chief Business Officer		Edgewise Therapeutics, Inc. - EWTX	0% 15.12K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 8:25 PM View:	23-Sep-24 Option Sale ($578.06K)	Moore John R General Counsel		Edgewise Therapeutics, Inc. - EWTX	0% 3.25K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 8:25 PM View:	20-Sep-24 Option Sale ($2.12M)	Russell Alan J Chief Scientific Officer Director		Edgewise Therapeutics, Inc. - EWTX	0% 12.72K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 8:24 PM View:	20-Sep-24 Private Sale ($202.60K)	Donovan Joanne M. CMO		Edgewise Therapeutics, Inc. - EWTX	(33%) 21.7K to 14.54K	0	0	--	--	Show Txns Hide Txns